Sahebi F, Kogut N, Spielberger R, Falk P, Nademanee A, Popplewell L, Maloney D, Rodriguez R, Krishnan A, Nakamura R, O’Donnell M, Parker P, Smith E, Stein A, Snyder D, Zain J, Qian D, Forman S, Somlo G. Allogeneic transplant with standard conditioning, reduced intensity, or non-myeloablative conditioning regimen for multiple myeloma (MM). 47th American Society of Hematologists, 2005.
Firoozeh S, Kogut N, Spielberger R, Falk P, Nademanee AP, Popplewell L, Maloney D, Rodriguez R, Krishnan A, Nakamura R, O’Donnell M, Parker P, Smith E, Stein A, Snyder D, Zain J, Qian D, Forman S, Somlo G. Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM). Ash-2005.
Stein AS, O'Donnell M, Parker P, Spielberger R, Nademanee AP, Bhatia R, Snyder DS, Kirschbaum M, PullarkatV, Kogut N, Bolotin E, Chang K, Sarkodee-Adoo C, Slovak M, Vora N, Land J, Dagis A, Palmer J, Forman SJ. Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) – a 15 Year Experience. ASH 2004.
Wang S, Nademanee AP, Park HS, Fridey J, Palmer J, Smith E, Snyder D, Somlo G, Bhatia R, Falk P, Kirschbaum M, Kogut N, Krishnan A, Margolin K, Nakamura R, O'Donnell M, Parker P, Popplewell L, Pullarkat V, Dajun Q, Rodriguez R, Rosenthal J, Spielberger R, Stein A, Yee D, Zain J, Forman SJ. Evaluating the Clinical Efficacy of Increased Granulocyte Colony-Stimulating Factor (GCSF) in Patients Who Fail a Standard Dose Regimen during Peripheral Blood Stem Cell (PBSC) Collection. ASH 2004.
Fung HC, Wang S, Nademanee AP, Cohen S, O’Donnell M, Falk P, Kogut N, Krishnan A, Molina A, Parker P, Popplewell L, Rodriguez R, Sahebi F, Smith D, Snyder D, Stein A, Spielberger R, Bhatia R, Bhatia S, Somlo G, Vora N, Forman SJ. Autologous Peripheral Stem Cell Transplantation (ABSCT) for Adult Patients with Hodgkin’s Disease (HD): Impact of Mobilization Kinetics on Transplant Outcome. ASH 2002.
Fung HC, Cohen S, Dagis A, O’Donnell M, Falk P, Kogut N, Krishnan A, Molina A, Nademanee AP, Parker P, Popplewell L, Rodriguez R, Slovak M, Sahebi F, Smith D, Spielberger R, Stein A, Snyder D, Vora N, Wong K, Bhatia R, Bhatia S, Somlo G, Forman SJ. Long Term Follow-up Report on Allogeneic Stem Cell Transplantation (alloSCT) for Patients with Acute Myelogenous Leukemia (AML) in First Relapse (Rel) or 2nd Complete Remission (Cr): Analysis of Prognostic Factors. ASH 2002.
Cohen S, Fung H, Stein A, Nademanee AP, Rodriguez R, O’Donnell M, Parker P, Molina A, Margolin K, Somlo G, Sahebi F, Spielberger R, Snyder D, Krishnan A, Popplewell L, Falk P, Kogut N, Smith D, Forman SJ. Reduced Intensity Allogeneic Stem Cell Transplantation for patients Who Have Failed a Prior Autologous Stem Cell Transplant. ASH 2002.
Lopez A, Parker P, Rodriguez R, Snyder D, Bhatia R, Cohen S, Fung H, Kashyap, Krishnan A, Molina A, Nademanee AP, O’Donnell M, Popplewell L, Rosenthal J, Sahebi F, Somlo G, Spielberger R, Stein A, Sweetman R, Forman S. Efficacy of Mycophenolate Mofetil (MMF) in Treatment of Chronic Graft Versus Host Disease. Blood 98 (11) 1673, 2001.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 06/08.
